“Correlation of FOXA1 protein expression and ER, PR and Her2 expression in breast cancer patients”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 433–436, Sep. 2022, doi: 10.47750/pnr.2022.13.03.066.